Skip to main content

Research Repository

Advanced Search

Outputs (26)

Incorporating FRAX into a nurse-delivered integrated care review: a multi-method qualitative study. (2023)
Journal Article
Hawarden, A., Bullock, L., Chew-Graham, C., Herron, D., Hider, S., Jinks, C., …Paskins, Z. (2023). Incorporating FRAX into a nurse-delivered integrated care review: a multi-method qualitative study. British Journal of General Practice Open (BJGP Open), 7(2), https://doi.org/10.3399/BJGPO.2022.0146

Background: People with inflammatory rheumatological conditions (IRCs) are at increased risk of common comorbidities including osteoporosis. Aim: To explore the barriers to and facilitators of implementing nurse-delivered fracture risk assessments... Read More about Incorporating FRAX into a nurse-delivered integrated care review: a multi-method qualitative study..

Exploring the treatment burden of disease modifying anti rheumatic drug monitoring in people with rheumatoid arthritis (2023)
Journal Article
Ryan, S., Bullock, L., Manning, F., Chew-Graham, C. A., & Paskins, Z. (in press). Exploring the treatment burden of disease modifying anti rheumatic drug monitoring in people with rheumatoid arthritis. Rheumatology Advances in Practice, 7(2), Article rkad054. https://doi.org/10.1093/rap/rkad054

Objectives People with rheumatoid arthritis (RA) taking disease-modifying anti-rheumatic drugs (DMARDs) require safety monitoring to identify potential side-effects. This study aimed to explore patients’ and family members’ perspectives on DMARD moni... Read More about Exploring the treatment burden of disease modifying anti rheumatic drug monitoring in people with rheumatoid arthritis.

Research priorities regarding the use of bisphosphonates for osteoporosis: a UK priority setting exercise (2023)
Journal Article
Paskins, Z., Moult, A., Corp, N., Bastounis, A., Davis, S., Narayanasamy, M. J., …Sahota, O. (2023). Research priorities regarding the use of bisphosphonates for osteoporosis: a UK priority setting exercise. Osteoporosis International, 10.1007/s00198-023-06806-7. https://doi.org/10.1007/s00198-023-06806-7

Worldwide, many people who would benefit from osteoporosis drugs are not offered or receiving them, resulting in an osteoporosis care gap. Adherence with bisphosphonates is particularly low. This study aimed to identify stakeholder research prioritie... Read More about Research priorities regarding the use of bisphosphonates for osteoporosis: a UK priority setting exercise.

AB1595 HOW DO WE PREVENT THE DEVELOPMENT OF MULTIMORBIDITY IN PEOPLE WITH INFLAMMATORY RHEUMATOLOGICAL DISORDERS: A QUALITATIVE INVESTIGATION (2023)
Journal Article
Grey, L., Bullock, L., Chew-Graham, C. A., Jinks, C., Paskins, Z., Rule, T., & Hider, S. (2023). AB1595 HOW DO WE PREVENT THE DEVELOPMENT OF MULTIMORBIDITY IN PEOPLE WITH INFLAMMATORY RHEUMATOLOGICAL DISORDERS: A QUALITATIVE INVESTIGATION. Annals of the Rheumatic Diseases, 82(Suppl 1), 2031 - 2031. https://doi.org/10.1136/annrheumdis-2023-eular.5564

Background: People with inflammatory rheumatological disorders (IRDs) are at high risk of developing multimorbidity, specifically cardiovascular disease (CVD) and mood problems. UK guidelines advocate annual reviews for people with Rheumatoid Arthrit... Read More about AB1595 HOW DO WE PREVENT THE DEVELOPMENT OF MULTIMORBIDITY IN PEOPLE WITH INFLAMMATORY RHEUMATOLOGICAL DISORDERS: A QUALITATIVE INVESTIGATION.

Thinking differently: evidence on what patients want and need in an explanation about osteoarthritis (2023)
Journal Article
Jinks, C., Campbell, L., Croft, P., Dziedzic, K., Grossman, H., Maddison, J., …Cottrell, L. (2023). Thinking differently: evidence on what patients want and need in an explanation about osteoarthritis. Osteoarthritis and Cartilage, 31(5), 711-712. https://doi.org/10.1016/j.joca.2023.02.064

Purpose: Osteoarthritis (OA) is a major cause of pain and disability worldwide. Despite this and the existence of evidence-based guidelines, many patients and professionals lack clarity about the nature of OA and effective treatment strategies. Healt... Read More about Thinking differently: evidence on what patients want and need in an explanation about osteoarthritis.

P082 Research priorities regarding the use of bisphosphonates for osteoporosis: a UK priority setting exercise (2023)
Presentation / Conference
Paskins, Z., Moult, A., Corp, N., Bastounis, A., Davis, S., Narayanasamy, M. J., …Sahota, O. (2023, April). P082 Research priorities regarding the use of bisphosphonates for osteoporosis: a UK priority setting exercise. Poster presented at British Society for Rheumatology Annual Conference 2023, Manchester Central Convention Complex, Manchester, UK

P083 How are beliefs about osteoporosis medicines elicited and addressed in clinical consultations: a video observational study (2023)
Presentation / Conference
Hawarden, A. W., Bullock, L., León-García, M., Hartasanchez, S. A., Hargraves, I., Horne, R., …Paskins, Z. (2023, April). P083 How are beliefs about osteoporosis medicines elicited and addressed in clinical consultations: a video observational study. Poster presented at British Society for Rheumatology Annual Conference 2023, Manchester Central Convention Complex, Manchester, UK

E060 Testing a new prototype osteoporosis shared decision-making intervention in UK Fracture Liaison Services: patient and clinician perspectives of ‘iFraP’ (2023)
Presentation / Conference
Bullock, L., Tyler, N., Thompson, M., Ryan, S., Lefroy, J., Leyland, S., …Paskins, Z. (2023, April). E060 Testing a new prototype osteoporosis shared decision-making intervention in UK Fracture Liaison Services: patient and clinician perspectives of ‘iFraP’. Poster presented at British Society for Rheumatology Annual Conference 2023, Manchester Central Convention Complex, Manchester, UK

Shared decision-making (SDM) is a joint process in which a person and healthcare professional work together to reach decisions about care. The Improving uptake of Fracture Prevention drug treatments (iFraP) study developed a prototype theoretically-i... Read More about E060 Testing a new prototype osteoporosis shared decision-making intervention in UK Fracture Liaison Services: patient and clinician perspectives of ‘iFraP’.